Parkinson’s disease: towards better preclinical models and personalized treatments

被引：0
|
作者：
Dan Lindholm
Johanna Mäkelä
Valentina Di Liberto
Giuseppa Mudò
Natale Belluardo
Ove Eriksson
Mart Saarma
机构：
[1] University of Helsinlki,Medicum, Department of Biochemistry and Developmental Biology, Medical Faculty
[2] Minerva Medical Research Institute,Division of Human Physiology, Department of Experimental Biomedicine and Clinical Neuroscience
[3] Biomedicum-2 Helsinki,undefined
[4] University of Palermo,undefined
[5] Institute of Biotechnology,undefined
[6] University of Helsinki,undefined
来源：
Cellular and Molecular Life Sciences | 2016年 / 73卷
关键词：
MPTP; Dopamine Neuron; Rasagiline; Neurotropic Factor; Respiratory Chain Deficiency;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1383 / 1385
页数：2
相关论文
共 50 条
  • [41] Constipation - A preclinical marker of Parkinson's disease
    Rana, M. A.
    Rana, A. Q.
    Mujawaz, Y.
    MOVEMENT DISORDERS, 2013, 28 : S308 - S309
  • [42] Aminochrome as preclinical model for Parkinson's disease
    Segura-Aguilar, Juan
    ONCOTARGET, 2017, 8 (28) : 45036 - 45037
  • [43] Towards better cellular replacement therapies in Parkinson disease
    Sun, Alfred Xuyang
    Tan, Eng-King
    JOURNAL OF NEUROSCIENCE RESEARCH, 2018, 96 (02) : 219 - 221
  • [44] Understanding cognitive deficits in Parkinson's disease: lessons from preclinical animal models
    Solari, Nicola
    Bonito-Oliva, Alessandra
    Fisone, Gilberto
    Brambilla, Riccardo
    LEARNING & MEMORY, 2013, 20 (10) : 592 - 600
  • [45] Changes in plasma catecholamines levels as preclinical biomarkers in experimental models of Parkinson’s disease
    A. R. Kim
    M. V. Ugryumov
    Doklady Biochemistry and Biophysics, 2015, 464 : 308 - 311
  • [46] Changes in plasma catecholamines levels as preclinical biomarkers in experimental models of Parkinson's disease
    Kim, A. R.
    Ugryumov, M. V.
    DOKLADY BIOCHEMISTRY AND BIOPHYSICS, 2015, 464 (01) : 308 - 311
  • [47] Preclinical Models of Multiple Sclerosis: Advantages and Limitations Towards Better Therapies
    Didonna, Alessandro
    CURRENT MEDICINAL CHEMISTRY, 2016, 23 (14) : 1442 - 1459
  • [48] Parkinson's Disease 3 Medical, surgical, and physical treatments for Parkinson's disease
    Foltynie, Tom
    Bruno, Veronica
    Fox, Susan
    Kuehn, Andrea A.
    Lindop, Fiona
    Lees, Andrew J.
    LANCET, 2024, 403 (10423): : 305 - 324
  • [49] Precision medicine in Parkinson's disease: emerging treatments for genetic Parkinson's disease
    Schneider, Susanne A.
    Alcalay, Roy N.
    JOURNAL OF NEUROLOGY, 2020, 267 (03) : 860 - 869
  • [50] Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
    Susanne A. Schneider
    Roy N. Alcalay
    Journal of Neurology, 2020, 267 : 860 - 869
12345